We've changed the way you complete courses

In response to user feedback we have simplified the way courses can be completed.

Until now you needed to complete the topics and modules in order, from start to finish. But from today you can complete them in any order you wish.

Just visit any topic that interests you, and when you are ready mark it as completed by clicking the green 'Mark complete' button at the bottom of the page.

Once you have completed all of the topics in a module an assessment will be provided for you.

Complete all the assessments to finish the course.

Thanks, I've got it! X

  • There is still an unclear understanding of the pathogenesis of the disease, but the immune system plays a central role
  • Short term immune modulation can temporarily arrest the loss of functional beta-cell mass
  • Type 1 diabetes is a heterogeneous disease and is heterogeneous also in response to immune modulotherapy
  • The target organ is hard to reach and biomarkers are not very good – we have mainly peripheral blood
  • We lack a robust and reliable animal model of disease
  • We need to balance the side-effects of potentially interesting, combination therapies versus living with type 1 diabetes